Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,020 | 169,402 | 24,897 | 11,899 | 21,287 |
| Marketable Securities | 173,023 | 133,581 | 59,065 | 41,413 | 39,811 |
| Receivables | 427 | 489 | 44 | 170 | 324 |
| TOTAL | $204,985 | $305,189 | $85,114 | $54,684 | $62,947 |
| Non-Current Assets | |||||
| PPE Net | 10,535 | 9,973 | 7,205 | 9,093 | 10,832 |
| Intangibles | 30,772 | 31,785 | 32,798 | 33,888 | 35,801 |
| Other Non-Current Assets | 1,722 | 148 | 424 | 329 | 363 |
| TOTAL | $43,029 | $41,906 | $40,427 | $43,310 | $46,996 |
| Total Assets | $248,014 | $347,095 | $125,541 | $97,994 | $109,943 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 5,592 | 6,136 | 13,523 |
| Accounts payable and accrued liabilities | 2,603 | 2,243 | 745 | 935 | 931 |
| Accrued Expenses | 19,296 | 17,179 | 10,960 | 7,008 | 4,936 |
| Other current liabilities | 2,592 | 928 | 388 | 219 | 818 |
| TOTAL | $24,491 | $20,350 | $17,685 | $14,298 | $20,208 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 5,746 | 9,008 | 8,889 |
| Other Non-Current Liabilities | 11,863 | 6,950 | 6,336 | 5,966 | 5,591 |
| TOTAL | $11,863 | $6,950 | $12,082 | $14,974 | $14,480 |
| Total Liabilities | $36,354 | $27,300 | $29,767 | $29,272 | $34,688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,977 | 5,953 | 5,376 | 3,813 | 2,138 |
| Common Shares | 90 | 89 | 64 | 44 | 32 |
| Retained earnings | -463,759 | -345,679 | -264,129 | -205,006 | -160,207 |
| Other shareholders' equity | 2,590 | 2,668 | 2,745 | 2,652 | 2,751 |
| TOTAL | $211,660 | $319,795 | $95,774 | $68,722 | $75,255 |
| Total Liabilities And Equity | $248,014 | $347,095 | $125,541 | $97,994 | $109,943 |